Sun Country Airlines Will Participate at the Morgan Stanley 12th Annual Laguna Conference
MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) — Sun Country Airlines (NASDAQ: SNCY) Senior Vice President and Chief Revenue Officer Grant […]
Bob Regnier Joins the Board of Directors of Each of Hawthorn Bank and Hawthorn Bancshares, Inc. Underscoring Their Commitment to Community Banking
JEFFERSON CITY, Mo., Sept. 03, 2024 (GLOBE NEWSWIRE) — Bob Regnier will join the Board of Directors of each of […]
Five Star Bancorp opens San Francisco office, bringing personalized, concierge banking services to the San Francisco Bay Area
RANCHO CORDOVA, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a […]
EzFill Holdings, Inc. Regains Compliance with NASDAQ Listing Standard
MIAMI, FL, Sept. 03, 2024 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill”) or the “Company”) (NASDAQ: EZFL), a pioneer and […]
Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval […]
DT Cloud Acquisition Corporation Signs Letter of Intent for a Business Combination
New York, New York, Sept. 03, 2024 (GLOBE NEWSWIRE) — DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (the “Company”) […]
Trust Stamp Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market, for Aggregate Gross Proceeds of $2.0 Million
Atlanta, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered software used […]
VCI Global Secures Approximately US$18 Million Contract for IPO Deals
KUALA LUMPUR, Malaysia, Sept. 03, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or […]
Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s […]
